# Boston Scientific Sets 2026 Earnings Outlook Below Consensus

By John Kim

Canonical URL: https://www.tokenpost.com/news/business/42564
Published: 2026-10-28T12:02:36.000Z
Updated: 2026-10-28T12:02:36.000Z
Section: Business

> Third-quarter revenue reached $5.14 billion, while non-GAAP earnings were 73 cents per share, 1 cent above estimates.

Boston Scientific set its 2026 adjusted earnings outlook at $3.16 to $3.18 a share, below the $3.23 consensus estimate, while reporting third-quarter revenue growth of 1.4%.

Revenue totaled $5.14 billion, $90 million above consensus. Non-GAAP earnings were 73 cents per share, beating estimates by 1 cent.

The company forecast reported sales growth of about 4.25% for 2026.